BI-706321
- Generic Name
- BI-706321
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 48
- Registration Number
- NCT05183360
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 49
- Registration Number
- NCT04978493
- Locations
- 🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸Southern Star Research Institute, LLC, San Antonio, Texas, United States
🇺🇸University of Utah Health Sciences Center, Salt Lake City, Utah, United States
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT04714073
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 61
- Registration Number
- NCT03971695
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath